mHealth Trials Are Happening, Without the Clinic

Scott Mace, for HealthLeaders Media , December 4, 2012

But that's today's apps. Tomorrow's apps will talk to an array of devices and sensors, some possibly inside the human body. Will all those devices and sensors be FDA-approved? Should they be? Many of them will require regular recalibration. Who will be managing that? Human beings are fallible. Can the technology be made self-calibrating? Or will the burden fall upon healthcare providers, who may find that their ACO status requires them to keep home health care devices in tune?

Then there's the dilemma of the regulators, if they suddenly find themselves charged with regulating 1s and 0s instead of just drugs and devices. To some extent, though, they already are in the software business.

Software technology is so malleable that it's unlikely that the clinical trial methodology we've used for drugs and devices could easily be adapted, or scaled, to regulate something like an app. Human factors often determine whether or not an app gets used correctly or not.

Perhaps, in the end, we'll just trust the technology as we do in so many other areas of life. Think of how modern jetliners couldn't fly without complex software systems managing the details. Self-driving cars have been sighted in my neighborhood in California. An amazingly tricky landing on Mars seemed like a piece of cake thanks to technology. Why shouldn't we trust more and more apps to manage our health?

Probably because nothing is more personal than one's health and well being. While the average app won't have the scientific might of the Jet Propulsion Laboratory behind it, we're going to be scrutinizing these apps even more closely. The trials are under way. They're just not happening in the clinic.

Scott Mace is senior technology editor at HealthLeaders Media.
1 | 2 | 3 | 4

Comments are moderated. Please be patient.

1 comments on "mHealth Trials Are Happening, Without the Clinic"

Wayne Caswell (12/5/2012 at 8:48 AM)
Will the consumer medical device and app be more accurate or helpful than the average general practitioner, or the mediocre one, or the top-notch one? Will low prices extend availability to more people and justify trade offs? Who gets to decide: consumers, medical practitioners, health institutions, insurers, employers, or regulators, and what will influence their decision? What might be the role of advertising? This is a relatively new and fast growing area with lots of unanswered questions. So, what may trigger government regulators to seek answers?




FREE e-Newsletters Join the Council Subscribe to HL magazine


100 Winners Circle Suite 300
Brentwood, TN 37027


About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2016 a division of BLR All rights reserved.